11 research outputs found
Modified study design for the R. Faleme focus.
<p>Modified study design for the R. Faleme focus.</p
Trend in prevalence of mf in the R. Faleme focus.
*<p>Source: Diawara et al <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001825#pntd.0001825-Diawara1" target="_blank">[17]</a>.</p
Location of the three study foci in Mali and Senegal.
<p>Location of the three study foci in Mali and Senegal.</p
Trend in prevalence of mf in the R. Bakoye focus.
*<p>Source: Diawara et al <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001825#pntd.0001825-Diawara1" target="_blank">[17]</a>.</p
Trend in prevalence of mf in the R. Gambia focus.
*<p>Source: Diawara et al <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001825#pntd.0001825-Diawara1" target="_blank">[17]</a>.</p
Trend in vector infectivity rate in the R. Faleme focus.
*<p>Source: Diawara et al <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001825#pntd.0001825-Diawara1" target="_blank">[17]</a>.</p
Prevalence of onchocerciasis infection in the R. Bakoye focus before the start of treatment and 1.75–4 years after the last treatment round.
<p>Prevalence of onchocerciasis infection in the R. Bakoye focus before the start of treatment and 1.75–4 years after the last treatment round.</p
Trend in vector infectivity rate in the R. Gambia focus.
*<p>Source: Diawara et al <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001825#pntd.0001825-Diawara1" target="_blank">[17]</a>.</p